• ABOUT
  • UNBUZZD™
  • LUCID-MS
  • INVESTORS
  • TEAM
  • NEWS & EVENTS
  • QUANTUM VS BANKS
  • WHISTLEBLOWER
  • CONTACT
  • Australian Subsidiaries
NASDAQ:QNTM
CSE:QNTM| FRA:0K91
Logo of Quantum Biopharma. Click to go to a Home page
NASDAQ:QNTM
Logo of Quantum Biopharma. Click to go to a Home page
  • ABOUT
  • UNBUZZD™
  • LUCID-MS
  • Investors
  • TEAM
  • NEWS & EVENTS
  • QUANTUM VS BANKS
  • WHISTLEBLOWER
  • CONTACT
  • Australian Subsidiaries

Annual General Meeting Materials

☰  IR MENU
  • Investors
  • Events
  • Press Releases
  • Financials & Filings
    • SEC Filings
    • Financial Results
    • Annual Reports
    • SEDAR+
    • Annual General Meeting Materials
  • Stock Info
  • Governance
  • Investor FAQ
  • Email Alerts
  • Investors
  • Events
  • Press Releases
  • Financials & Filings
    • SEC Filings
    • Financial Results
    • Annual Reports
    • SEDAR+
    • Annual General Meeting Materials
  • Stock Info
  • Governance
  • Investor FAQ
  • Email Alerts

Notice of Annual General and Special Meeting

Download PDF

Proxy  Card

Download PDF

Voting Instruction Form

Download PDF

Notice of Availability for Proxy Materials

Download PDF

Supplemental Template

Download PDF

Management Information Circular

Download PDF
A blue and white dna molecule on a white background.

© Copyright 2026 Quantum BioPharma. All Rights Reserved. Powered by ACCESS Newswire.

Investor Relations

IR@QuantumBioPharma.com

General Inquiries

www.quantumbiopharma.com/contact

info@quantumbiopharma.com

1-833-304-0323

Principal Executive Office

1 Adelaide Street East, Suite 801

Toronto, Ontario M5C 2V9

Email Alerts

Sign Up Today
Share by: